← Leaderboards
Eileen Tsai Chambers
Duke University
$442,750
Attributed
$442,750
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $241.5K · FY2021–22$250K$187.5K$125K$62.5K$0
'21
'22
Funding mix
By agency
NIH$442,750 · 1
By mechanism
R21$442,750 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Alisa S Wolberg$13,659,847
- Jean Kwun$6,486,375
- Aravind Asokan$26,081,479
- Russell E Ware$48,672,245
- Scott M Palmer$46,531,610
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultAllograftingAnimalsAntibodiesAntibody FormationAntibody-Mediated RejectionAntibody TherapyAntigensAutoimmune DiseasesBaseBiomedical EngineeringBloodBlood CellsBlood CirculationBlood Coagulation FactorBlood Component RemovalBlood PlateletsBlood SpecimenBlood TransfusionBlood VolumeCellsCell SeparationCellular StructuresAcoustics
Grant awards (2)
Development of a novel acoustofluidic device for targeted antibody removal in pediatric organ transplant rejection$241,500
R21 · FY2022 · HD · contact PI
Development of a novel acoustofluidic device for targeted antibody removal in pediatric organ transplant rejection$201,250
R21 · FY2021 · HD · contact PI